Mouse models for FXTAS and the fragile X premutation

Molly M. Foote, Milo Careaga, Ronald A.M. Buijsen, Robert F Berman, Rob Willemsen, Renate K. Hukema

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The use of model organisms is essential in order to understand the pathogenesis of many types of human disease, and this is particularly true for the study of genetic diseases such as fragile X syndrome and fragile X-associated tremor/ataxia syndrome (FXTAS). In reverse genetics, the functional study of a gene starts with the question of how a possible phenotype may derive from a specific genetic sequence (disease-causing mutation in a gene). As a first step, a gene function is purposefully altered and the effect on the normal development and/or behavior of the model organism is analyzed. In addition to providing knowledge about the cellular and molecular mechanisms underlying specific genes and their functions, animal models of human disease also provide systems for developing and validating therapeutic strategies. The choice of which animal model is most suitable to mimic a particular disease depends on a range of factors, including anatomical, physiological, and pathological similarity; presence of orthologs of genes of interest; and conservation of basic cell biological and metabolic processes. In this chapter, we will discuss two model organisms, a mammalian vertebrate (mouse) and an invertebrate model (fly), which have been generated to study the pathogenesis of FXTAS and the effects of potential therapeutic interventions. Both mouse and fly models have proven invaluable for the study of the pathophysiology of FXTAS, including insights into the role of mutant mRNA in this disease (i.e., RNA gain-of-function mechanisms, see Chap.

Original languageEnglish (US)
Title of host publicationFXTAS, FXPOI, and Other Premutation Disorders
PublisherSpringer International Publishing
Pages161-179
Number of pages19
ISBN (Electronic)9783319338989
ISBN (Print)9783319338965
DOIs
StatePublished - Jan 1 2016

Fingerprint

Genes
Inborn Genetic Diseases
Diptera
Animals
Biological Phenomena
Animal Disease Models
Reverse Genetics
Fragile X Syndrome
Therapeutic Uses
Invertebrates
Vertebrates
Animal Models
Fragile X Tremor Ataxia Syndrome
RNA
Conservation
Phenotype
Messenger RNA
Mutation
Therapeutics

Keywords

  • Animal models
  • Behavior
  • Drosophila
  • Early onset
  • FMRP
  • FXTAS
  • Intranuclear inclusions
  • MicroRNA
  • Mouse
  • Premutation
  • RAN translation
  • Therapies

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Neuroscience(all)

Cite this

Foote, M. M., Careaga, M., Buijsen, R. A. M., Berman, R. F., Willemsen, R., & Hukema, R. K. (2016). Mouse models for FXTAS and the fragile X premutation. In FXTAS, FXPOI, and Other Premutation Disorders (pp. 161-179). Springer International Publishing. https://doi.org/10.1007/978-3-319-33898-9_8

Mouse models for FXTAS and the fragile X premutation. / Foote, Molly M.; Careaga, Milo; Buijsen, Ronald A.M.; Berman, Robert F; Willemsen, Rob; Hukema, Renate K.

FXTAS, FXPOI, and Other Premutation Disorders. Springer International Publishing, 2016. p. 161-179.

Research output: Chapter in Book/Report/Conference proceedingChapter

Foote, MM, Careaga, M, Buijsen, RAM, Berman, RF, Willemsen, R & Hukema, RK 2016, Mouse models for FXTAS and the fragile X premutation. in FXTAS, FXPOI, and Other Premutation Disorders. Springer International Publishing, pp. 161-179. https://doi.org/10.1007/978-3-319-33898-9_8
Foote MM, Careaga M, Buijsen RAM, Berman RF, Willemsen R, Hukema RK. Mouse models for FXTAS and the fragile X premutation. In FXTAS, FXPOI, and Other Premutation Disorders. Springer International Publishing. 2016. p. 161-179 https://doi.org/10.1007/978-3-319-33898-9_8
Foote, Molly M. ; Careaga, Milo ; Buijsen, Ronald A.M. ; Berman, Robert F ; Willemsen, Rob ; Hukema, Renate K. / Mouse models for FXTAS and the fragile X premutation. FXTAS, FXPOI, and Other Premutation Disorders. Springer International Publishing, 2016. pp. 161-179
@inbook{fc745799dd4443d6bc37621e97b19d37,
title = "Mouse models for FXTAS and the fragile X premutation",
abstract = "The use of model organisms is essential in order to understand the pathogenesis of many types of human disease, and this is particularly true for the study of genetic diseases such as fragile X syndrome and fragile X-associated tremor/ataxia syndrome (FXTAS). In reverse genetics, the functional study of a gene starts with the question of how a possible phenotype may derive from a specific genetic sequence (disease-causing mutation in a gene). As a first step, a gene function is purposefully altered and the effect on the normal development and/or behavior of the model organism is analyzed. In addition to providing knowledge about the cellular and molecular mechanisms underlying specific genes and their functions, animal models of human disease also provide systems for developing and validating therapeutic strategies. The choice of which animal model is most suitable to mimic a particular disease depends on a range of factors, including anatomical, physiological, and pathological similarity; presence of orthologs of genes of interest; and conservation of basic cell biological and metabolic processes. In this chapter, we will discuss two model organisms, a mammalian vertebrate (mouse) and an invertebrate model (fly), which have been generated to study the pathogenesis of FXTAS and the effects of potential therapeutic interventions. Both mouse and fly models have proven invaluable for the study of the pathophysiology of FXTAS, including insights into the role of mutant mRNA in this disease (i.e., RNA gain-of-function mechanisms, see Chap.",
keywords = "Animal models, Behavior, Drosophila, Early onset, FMRP, FXTAS, Intranuclear inclusions, MicroRNA, Mouse, Premutation, RAN translation, Therapies",
author = "Foote, {Molly M.} and Milo Careaga and Buijsen, {Ronald A.M.} and Berman, {Robert F} and Rob Willemsen and Hukema, {Renate K.}",
year = "2016",
month = "1",
day = "1",
doi = "10.1007/978-3-319-33898-9_8",
language = "English (US)",
isbn = "9783319338965",
pages = "161--179",
booktitle = "FXTAS, FXPOI, and Other Premutation Disorders",
publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Mouse models for FXTAS and the fragile X premutation

AU - Foote, Molly M.

AU - Careaga, Milo

AU - Buijsen, Ronald A.M.

AU - Berman, Robert F

AU - Willemsen, Rob

AU - Hukema, Renate K.

PY - 2016/1/1

Y1 - 2016/1/1

N2 - The use of model organisms is essential in order to understand the pathogenesis of many types of human disease, and this is particularly true for the study of genetic diseases such as fragile X syndrome and fragile X-associated tremor/ataxia syndrome (FXTAS). In reverse genetics, the functional study of a gene starts with the question of how a possible phenotype may derive from a specific genetic sequence (disease-causing mutation in a gene). As a first step, a gene function is purposefully altered and the effect on the normal development and/or behavior of the model organism is analyzed. In addition to providing knowledge about the cellular and molecular mechanisms underlying specific genes and their functions, animal models of human disease also provide systems for developing and validating therapeutic strategies. The choice of which animal model is most suitable to mimic a particular disease depends on a range of factors, including anatomical, physiological, and pathological similarity; presence of orthologs of genes of interest; and conservation of basic cell biological and metabolic processes. In this chapter, we will discuss two model organisms, a mammalian vertebrate (mouse) and an invertebrate model (fly), which have been generated to study the pathogenesis of FXTAS and the effects of potential therapeutic interventions. Both mouse and fly models have proven invaluable for the study of the pathophysiology of FXTAS, including insights into the role of mutant mRNA in this disease (i.e., RNA gain-of-function mechanisms, see Chap.

AB - The use of model organisms is essential in order to understand the pathogenesis of many types of human disease, and this is particularly true for the study of genetic diseases such as fragile X syndrome and fragile X-associated tremor/ataxia syndrome (FXTAS). In reverse genetics, the functional study of a gene starts with the question of how a possible phenotype may derive from a specific genetic sequence (disease-causing mutation in a gene). As a first step, a gene function is purposefully altered and the effect on the normal development and/or behavior of the model organism is analyzed. In addition to providing knowledge about the cellular and molecular mechanisms underlying specific genes and their functions, animal models of human disease also provide systems for developing and validating therapeutic strategies. The choice of which animal model is most suitable to mimic a particular disease depends on a range of factors, including anatomical, physiological, and pathological similarity; presence of orthologs of genes of interest; and conservation of basic cell biological and metabolic processes. In this chapter, we will discuss two model organisms, a mammalian vertebrate (mouse) and an invertebrate model (fly), which have been generated to study the pathogenesis of FXTAS and the effects of potential therapeutic interventions. Both mouse and fly models have proven invaluable for the study of the pathophysiology of FXTAS, including insights into the role of mutant mRNA in this disease (i.e., RNA gain-of-function mechanisms, see Chap.

KW - Animal models

KW - Behavior

KW - Drosophila

KW - Early onset

KW - FMRP

KW - FXTAS

KW - Intranuclear inclusions

KW - MicroRNA

KW - Mouse

KW - Premutation

KW - RAN translation

KW - Therapies

UR - http://www.scopus.com/inward/record.url?scp=85018874173&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018874173&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-33898-9_8

DO - 10.1007/978-3-319-33898-9_8

M3 - Chapter

AN - SCOPUS:85018874173

SN - 9783319338965

SP - 161

EP - 179

BT - FXTAS, FXPOI, and Other Premutation Disorders

PB - Springer International Publishing

ER -